Fig. 8

Immune states in patients with non-aGVHD differ from those in healthy donors and patients with aGVHD. A UMAP plot of scRNA-seq data from PBMCs of healthy donors, patients with aGVHD and with non-aGVHD, with cell subtypes labeled. B Dot plots illustrating relative expression levels of selected genes in PBMCs obtained from healthy donors, patients with aGVHD, and patients with non-aGVHD. C mRNA expression levels of selected genes in bone marrow cells and splenic cells from control groups, mice with BM transplantation, and mice with aGVHD (day 4)